Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase PHF7 (PHF7) is a multidomain protein containing extended plant homeodomain (ePHD) and RING finger domains, acting as a RING-type E3 ubiquitin ligase. PHF7 is specifically and predominantly expressed in the male germline, where it is essential for proper progression of spermatogenesis and male fertility. PHF7's domains cooperate for substrate recognition and catalytic activity: the ePHD recognizes nucleosomal DNA, while its PHD domain binds to methylated lysine 4 of histone H3 (H3K4me2/3), acting as an epigenetic reader, and the RING domain confers E3 ubiquitin ligase activity, specifically targeting lysine 14 of histone H3 and histone H2A for ubiquitination. These modifications facilitate the critical histone-to-protamine exchange necessary for maturation of elongating spermatids. Loss of PHF7 impairs histone removal, resulting in male infertility due to defective chromatin remodeling. PHF7 additionally appears to promote and induce male germline identity and is involved in epigenetic regulation by coordinating histone binding and ubiquitination[1][2][3][4][5]. There are currently no drugs or clinical biomarkers linked to PHF7; its role is of scientific interest as a fundamental regulator of spermatogenesis and epigenetic reprogramming, but it is not considered a therapeutic target in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase PHF7 (PHF7).